Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Degeneration Saline group presented with significant decreased final weight in relation to other groups. حسب Flavia Gomes Velasque Gama (21175112)

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. حسب Farayi Kaseke (19560197)

الموضوعات:

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

The number, age, and weight of the patients with cleft lip and palate in the velar adhesion VA group and non-VA group. حسب Miki Kashiwagi (21439684)

الموضوعات:

Measurement of the patients’ dental cast models. حسب Miki Kashiwagi (21439684)

الموضوعات:

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

Velar adhesion (VA). حسب Miki Kashiwagi (21439684)

الموضوعات:

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. حسب Miki Kashiwagi (21439684)

الموضوعات:

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

The results of linear mixed model. حسب Soheila Qanbari (20455173)

الموضوعات:

The flow of the participants from enrollment to analysis. حسب Soheila Qanbari (20455173)

الموضوعات:

Correlation between treatment-induced changes in lumbar motor control and N150 amplitude. حسب Soheila Qanbari (20455173)

الموضوعات:

Sensory-evoked potentials of N80 and N150. حسب Soheila Qanbari (20455173)

الموضوعات:

The mean and standard deviation of outcome measures. حسب Soheila Qanbari (20455173)

الموضوعات:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. حسب Soheila Qanbari (20455173)

الموضوعات:

The demographical and clinical characteristics of subjects at baseline. حسب Soheila Qanbari (20455173)

الموضوعات: